Bas Oldenburg News Today

In patients with remitting inflammatory bowel disease, relapse after withdrawal of anti-tumor necrosis factor therapy is less likely if they have complete endoscopic healing, suggests a Dutch study.

Though about a third of these patients still relapsed after cessation of TNF inhibitors

Dutch study finds no greater loss of response, but higher risk of anti-drug antibodies